Hudson Valley Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
3,620
-269
-7% -$15.4K 0.03% 141
2026
Q1
$236K Sell
3,889
-200
-5% -$11.7K 0.03% 139
2025
Q4
$221K Sell
4,089
-2,800
-41% -$135K 0.02% 147
2025
Q3
$311K Buy
6,889
+900
+15% +$42K 0.03% 143
2025
Q2
$277K Sell
5,989
-4,220
-41% -$207K 0.03% 146
2025
Q1
$623K Sell
10,209
-319
-3% -$18.6K 0.07% 111
2024
Q4
$596K Sell
10,528
-1,982
-16% -$111K 0.07% 113
2024
Q3
$647K Sell
12,510
-2,916
-19% -$137K 0.07% 112
2024
Q2
$799K Buy
15,426
+1,391
+10% +$62.2K 0.1% 107
2024
Q1
$761K Sell
14,035
-1,091
-7% -$55.6K 0.09% 109
2023
Q4
$783K Sell
15,126
-2,225
-13% -$117K 0.11% 108
2023
Q3
$1.01M Sell
17,351
-1,316
-7% -$80.6K 0.14% 100
2023
Q2
$1.19M Sell
18,667
-1,024
-5% -$68.7K 0.16% 103
2023
Q1
$1.36M Sell
19,691
-315
-2% -$22.2K 0.19% 100
2022
Q4
$1.44M Sell
20,006
-580
-3% -$43.7K 0.22% 96
2022
Q3
$1.46M Sell
20,586
-837
-4% -$60.7K 0.23% 94
2022
Q2
$1.65M Sell
21,423
-830
-4% -$63.2K 0.26% 91
2022
Q1
$1.63M Sell
22,253
-615
-3% -$41.3K 0.22% 92
2021
Q4
$1.43M Sell
22,868
-100
-0.4% -$5.87K 0.22% 79
2021
Q3
$1.36M Sell
22,968
-785
-3% -$51.7K 0.23% 79
2021
Q2
$1.59M Sell
23,753
-1,150
-5% -$75K 0.28% 78
2021
Q1
$1.57M Sell
24,903
-1,100
-4% -$68.4K 0.28% 77
2020
Q4
$1.61M Sell
26,003
-300
-1% -$18.4K 0.31% 74
2020
Q3
$1.59M Sell
26,303
-890
-3% -$53.6K 0.34% 69
2020
Q2
$1.6M Sell
27,193
-376
-1% -$22.5K 0.37% 68
2020
Q1
$1.54M Sell
27,569
-436
-2% -$26.6K 0.43% 61
2019
Q4
$1.8M Buy
28,005
+6,320
+29% +$362K 0.38% 65
2019
Q3
$1.1M Buy
21,685
+5
+0% +$235 0.25% 81
2019
Q2
$983K Sell
21,680
-395
-2% -$18.4K 0.23% 89
2019
Q1
$1.05M Sell
22,075
-5,581
-20% -$278K 0.26% 83
2018
Q4
$1.44M Buy
27,656
+1,599
+6% +$85.9K 0.33% 75
2018
Q3
$1.62M Sell
26,057
-371
-1% -$22K 0.38% 73
2018
Q2
$1.46M Sell
26,428
-196
-0.7% -$10.6K 0.36% 75
2018
Q1
$1.68M Sell
26,624
-1,822
-6% -$117K 0.42% 67
2017
Q4
$1.74M Sell
28,446
-372
-1% -$23.3K 0.43% 66
2017
Q3
$1.84M Buy
28,818
+1,601
+6% +$93.5K 0.48% 61
2017
Q2
$1.52M Sell
27,217
-3,918
-13% -$213K 0.42% 68
2017
Q1
$1.69M Sell
31,135
-11,991
-28% -$658K 0.47% 64
2016
Q4
$2.52M Sell
43,126
-4,251
-9% -$232K 0.74% 45
2016
Q3
$2.56M Sell
47,377
-2,237
-5% -$144K 0.79% 40
2016
Q2
$3.65M Sell
49,614
-3,185
-6% -$225K 1.17% 27
2016
Q1
$3.37M Sell
52,799
-912
-2% -$57.5K 1.1% 30
2015
Q4
$3.69M Sell
53,711
-1,072
-2% -$70.8K 1.15% 28
2015
Q3
$3.24M Sell
54,783
-1,863
-3% -$118K 1.05% 31
2015
Q2
$3.77M Sell
56,646
-572
-1% -$37.7K 1.18% 28
2015
Q1
$3.69M Buy
57,218
+138
+0.2% +$8.64K 1.25% 29
2014
Q4
$3.37M Buy
57,080
+2,129
+4% +$120K 1.38% 31
2014
Q3
$2.81M Buy
54,951
+590
+1% +$29.5K 1.19% 34
2014
Q2
$2.64M Buy
54,361
+42
+0.1% +$2.07K 1.15% 34
2014
Q1
$2.82M Sell
54,319
-91
-0.2% -$4.84K 1.21% 34
2013
Q4
$2.89M Sell
54,410
-157
-0.3% -$8K 1.27% 31
2013
Q3
$2.52M Sell
54,567
-928
-2% -$40.7K 1.23% 33
2013
Q2
$2.48M Buy
+55,495
New +$2.41M 1.19% 32

Other funds holding BMY

Hudson Valley Investment Advisors's BMY Position: Q2 2026 in Review

Hudson Valley Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 6.9% in Q2 2026, selling an estimated $15.4K and leaving 3,620 shares worth $209K. The position accounts for 0.03% of the portfolio, ranked #141.

Hudson Valley Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.77M in Q2 2015. 843 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hudson Valley Investment Advisors held 3,620 shares of Bristol-Myers Squibb worth $209K as of Q2 2026.
  • Hudson Valley Investment Advisors sold 269 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.4K.
  • Bristol-Myers Squibb made up 0.03% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #141 holding.
  • Hudson Valley Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Hudson Valley Investment Advisors's Bristol-Myers Squibb position peaked at $3.77M in Q2 2015.
  • 843 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.